Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7218272
Reference Type
Journal Article
Title
Molecular docking, MM/GBSA and 3D-QSAR studies on EGFR inhibitors
Author(s)
Bathini, R; Sivan, SK; Fatima, S; Manga, V; ,
Year
2016
Is Peer Reviewed?
1
Journal
Proceedings of the Indian Academy of Sciences - Chemical sciences
ISSN:
0253-4134
Publisher
INDIAN ACAD SCIENCES
Location
BANGALORE
Page Numbers
1163-1173
DOI
10.1007/s12039-016-1103-3
Web of Science Id
WOS:000378943300017
Abstract
Epidermal growth factor receptor (EGFR) is the first growth factor receptor proposed as a target for cancer therapy. Molecular modeling protocols like molecular docking, molecular mechanics/generalized born surface area (MM/GBSA) calculations and three dimensional-quantitative structure activity relationship (3D-QSAR) studies were performed on 45 molecules to understand the structural requirements for EGFR tyrosine kinase inhibitors. Conformation for all the molecules obtained from molecular docking were used as is for 3D-QSAR analysis. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) models were obtained by performing partial least square analysis on 35 training molecules and these models were validated using 10 test moleucles. The models showed good statistical results in terms of r(2), q(loo)(2) and r(pred)(2) values. Information rendered from 3D-QSAR model and sitemap analysis was used to optimize lead molecule to design prospective inhibitors. Improvement in EGFR binding affinity can be achieved by substitutional modification on phenyl ring attached to alkynyl group with bulkier hydrogen bond donor and acceptor substituents that can increase favourable interaction with the receptor.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity